Telectronics
This article was originally published in The Gray Sheet
Executive Summary
Second-generation dual chamber pacemaker, the META DDDR 1254, receives FDA go-ahead to begin marketing. The device is smaller than the first generation META DDDR 1250H and has "several significant enhancements designed to improve function and ease of use," the company claims. Indications for use also are expanded to "patients with occasional atrial arrhythmias." A premarket approval application for the 1250H was approved in February 1992 ("The Gray Sheet" Feb. 10, 1992, p. 7).